Navigation Links
Zimmer Announces Early Clinical Success of Zimmer® MotionLoc™ Screw Implantation
Date:2/18/2011

SAN DIEGO, Feb. 18, 2011 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that early clinical results of the first patients treated with Zimmer MotionLoc™ Screws were free of complications.  The Zimmer MotionLoc Screw is Zimmer Trauma's latest advancement in locking plate technology and is intended for use in conjunction with the Zimmer NCB® Polyaxial Locking Plate System.  

The Zimmer MotionLoc Screw for the NCB Polyaxial Locking Plate System offers a new option to surgeons who treat complex long bone fractures, such as those of the femur, tibia or humerus.  This technology enables the surgeon to reduce the stiffness of the locking plate construct while still maintaining the strength needed until the fracture begins to heal.  Zimmer MotionLoc technology is based on the concept of Far Cortical Locking, which may reduce the stiffness of locked plating constructs while still retaining the construct's strength.

"This new technology builds on Zimmer's longstanding tradition of offering surgeons easy-to-use products in trauma care," said Jeff Paulsen, Group President, Zimmer Global Businesses.  "We believe this screw will prove to be a game-changer for surgeons treating complex long bone fractures, without drastically altering their surgical procedure."

A total of ten patients were treated using the Zimmer MotionLoc Screws between October 2010 and January 2011, and postoperatively, surgeons reported no complications in implant application, implant fixation or fracture healing.  Specifically, surgeons commented that insertion and removal of the Zimmer MotionLoc Screws felt normal and the procedures did not require additional effort compared to standard screw insertion. <
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Zimmer Launches PathFinder NXT™ Minimally Invasive Pedicle Screw System
2. Zimmer Showcases Newly Acquired Line of Surgical Power Tools at 2011 AAOS Annual Meeting
3. Zimmer Continuum® Acetabular System Becomes Zimmers Best Selling Hip Construct
4. Zimmer Reports Fourth Quarter and 2010 Financial Results
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Year End 2010 Results
6. Zimmer Introduces a Move Forward in Mobile Bearing Knee Design
7. Zimmer Announces Acquisition of SoPlus Orthopaedic Surgical Power Tools Company
8. Zimmer Finalizes Acquisition of Chinese Orthopaedic Implant Leader Beijing Montagne Medical Device Co., Ltd.
9. Zimmer Holdings to Present at 29th Annual J.P. Morgan Healthcare Conference
10. Zimmer Awarded Premium Pricing for Trabecular Metal™ Modular Cup in Japan
11. Zimmer® Announces 1000th Implantation of Its Natural Nail™ Cephalomedullary Nail
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 ResearchMoz presents this ...  Laparoscopes Market Outlook to 2020. New report, "United States ... on the United States Laparoscopes market . The ... (in units) and average prices (in US dollars) within ... Flexible Tip Video Laparoscopes), Robotic Surgical Systems and Rigid ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new market ... Baby Food Eastern Europe 2014 ... 2014" is a new report by ERC that analyzes ... Eastern Europe , key segments, features & developments, ... examines trends which are currently affecting the industry. Furthermore, ...
(Date:8/27/2014)... 27, 2014 Sihuan Pharmaceutical Holdings Group ... a leading pharmaceutical company with the largest cardio-cerebral ... prescription drug market, today announced the ... subsidiaries (collectively the "Group") for the six months ... Financial HighlightsFor the Six months ended 30 JuneKey ...
Breaking Medicine Technology:United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7
... in non-responders to previous interferon-based therapy -, ... non- responders, with less frequent ... Annual Meeting of the American Association for the Study of Liver Diseases ... (AASLD) -, ...
... N.C., Nov. 2 /PRNewswire/,-- Fabre-Kramer Pharmaceuticals Inc. (FKP) ... the U.S. Food and Drug Administration (FDA) has ... application for gepirone extended-,release (ER) tablets, submitted for ... The FDA had previously reviewed Phase I through ...
Cached Medicine Technology:Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder 2
(Date:8/27/2014)... clinical trial participation in the largest ongoing observational study ... not representative of the larger patient base, according to ... Jay Udell. The study authors call into question the ... and suggest the use of broader enrollment criteria and ... know that clinical trials can be tremendously expensive and ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Representatives with ... added Italy to its list of destinations for International ... for Recharge Retreats, explained that the company chose Italy ... destination for yoga teacher trainings since it's an easy ... journey for people traveling from all over Europe, UK, ...
(Date:8/27/2014)... TX (PRWEB) August 27, 2014 Many ... The reality is that depression has a mortality rate ... with bi-polar disorder is slightly less, though it's offset ... roughly 7%. In order to properly treat and ... and bi-polar, medication must be taken as directed. ...
(Date:8/27/2014)... California (PRWEB) August 27, 2014 Beginning in ... Daycare Olympic Games (DOG) as an interactive, fun way ... will be free to all K9 Dog Park Doggy Daycare ... least two days per week. Clients will be able ... daycare webcams. The dogs that compete in D.O.G. will ...
(Date:8/27/2014)... HealthDay Reporter TUESDAY, Aug. 26, 2014 ... for blood transfusions might also protect the brains of premature ... stimulates red blood cell production, appears to prevent brain damage ... Petra Huppi, a professor of pediatrics and newborn medicine at ... of whether EPO protects the brains of these children will ...
Breaking Medicine News(10 mins):Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 3Health News:MedicationDiscountCard.com now Makes Brintellix and Mental Illness Medications More Affordable with Discount Cards 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 3Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 4Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3
... Medicated heart patients might be in danger, study suggests ... boost blood pressure and heart rate and could pose ... Wayne State University researchers. , They found that drinking ... pressure and heart rate in 15 healthy adults, average ...
... controlled, multi-center trial has found that cardiac resynchronization ... during exercise testing, the trial,s primary endpoint, in ... problems that disrupt the heart,s normal rhythm and ... EKG. , The Resynchronization Therapy in Narrow QRS ...
... Nov. 6 ,PharmAthene, Inc. (Amex: PIP ), ... chemical threats, and Medarex, Inc.,(Nasdaq: MEDX ), ... FY 2008 Department of Defense (DoD) appropriations bill ... reimbursement basis to support,ongoing development of Valortim(TM), a ...
... Neurotech Pharmaceuticals, Inc.,a biotechnology company focused on ... diseases, announced today the completion,of enrollment of ... evaluating,NT-501, the Company,s lead product, for the ... (RP) and the dry form of age-related,macular ...
... EntreMed, Inc.,(Nasdaq: ENMD ), a clinical-stage pharmaceutical ... inflammatory diseases, today,reported results for the three and ... http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO ) Revenues for the third ... comparable period a year ago. The Company,reported a ...
... - Bioniche Life Sciences,Inc. (TSX: BNC), a research-based, ... Executive,Vice-President, Corporate & Strategic Development, will present at ... in New York City,tomorrow. Mr. Groome will present ... Room of the New York Palace Hotel. ...
Cached Medicine News:Health News:Energy Drinks Could Pose Blood Pressure Risks 2Health News:Study puts brakes on extending indications for cardiac resynchronization therapy 2Health News:PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM) 2Health News:PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM) 3Health News:PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM) 4Health News:PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM) 5Health News:PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM) 6Health News:PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM) 7Health News:Neurotech Announces Completion of Enrollment of its Phase II/III Retinitis Pigmentosa and Phase II Dry Age Related Macular Degeneration Clinical Studies 2Health News:Neurotech Announces Completion of Enrollment of its Phase II/III Retinitis Pigmentosa and Phase II Dry Age Related Macular Degeneration Clinical Studies 3Health News:EntreMed Reports Third Quarter 2007 Financial Results 2Health News:EntreMed Reports Third Quarter 2007 Financial Results 3Health News:EntreMed Reports Third Quarter 2007 Financial Results 4Health News:EntreMed Reports Third Quarter 2007 Financial Results 5Health News:Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: